 |
|
 |
|
 |
|
 |
|
´Ü¼øÇÑ
¾à¹°ÀÇ Á¤¸®³ª º¹½ÀÀÇ °úÁ¤ÀÌ ¾Æ´Ï¸ç ¾à¹° ¹× »ýü³» ¹°Áú¿¡ ´ëÇÑ
¼¼Æ÷¿¡¼ºÎÅÍ °³Ã¼´Ü°è±îÁöÀÇ
.. ¹ÝÀÀÀ»
ÀÌÇØÇϰíÀÚ ÇÏ´Â °üÁ¡¿¡¼ ¾à¸®Çб³½Ç¿¡¼ ÁøÇàÇϰí ÀÖ´Â ¿¬±¸¸¦ ¹ÙÅÁÀ¸·Î
ÇнÀ, ÅäÀÇ, ½Ç½ÀÇÑ´Ù
.. À̸¦ ÅëÇÏ¿© ÀåÂ÷ ÀÇÇÐÀڷμ ¿¬±¸¸¦ ±âȹÇϰí ÁøÇàÇØ ³ª°¡´Â ´É·ÂÀ»
ÇÔ¾çÇÑ´Ù. |
|
* 2ÇÐÁ¡, ÁÖ´ç 10 ½Ã°£ °ÀÇ 33 ½Ã°£ ½ÇÇè
* ´ë»ó : ÀÇÇаú 4Çгâ |
|
|
| |
 |
|
|
|
|
´ëºÐ¾ß:
¼Òȱ⠾ฮÇÐÁøÇà ¿¬±¸: ¿°Áõ¼º ¼Òȱâ Áúȯ ¿¬±¸
(Helicobacter pylori¿¡ ÀÇÇÑ À§Á¡¸· ¼Õ»ó ¹× ±Þ¼ºÃéÀå¿°ÀÇ º´ÀÎ ¿¬±¸) |
|
¿¬±¸
³»¿ë:
¨ç ÀÎü À§»óÇǼ¼Æ÷¿¡¼ H. pylori¿¡ ÀÇÇØ À¯µµµÇ´Â ¿°Áõ¸Å°³ cytokine (IL-1¥á, 1¥â, IL-6,
IL-8)ÀÇ »ý¼º¾ç»ó°ú ÇÙÀü»çÁ¶ÀýÀÎÀÚÀÎ NF-¥êB¿ÍÀÇ °ü°è¸¦ ±Ô¸íÇϰí, Ç×»êȹ°ÁúÀÌ cytokine »ý¼º°ú NF-¥êB
Ȱ¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÏ¿© ¿¬±¸ÇÑ´Ù.
À§¿° ¹× À§¾Ï ¹ß»ýÀÇ Áß¿äÇÑ º´ÀÎÀ¸·Î ¾Ë·ÁÁø H. pylori¿¡ ´ëÇÏ¿© Ä£¿°Áõ¼º cytokineÀÎ IL-8, MCP-1ÀÇ
¹ßÇö ¹× Á¶Àý±âÀüÀ» ¿¬±¸Çϸç, ³ª¶ó¿¡ µû¸¥ H. pylori subtype º¯È¿¡ ´ëÇÑ ¿°Áõ¸Å°³ cytokineÀÇ
¹ßÇö¾ç»ó º¯È ±×¸®°í H. pyloriÀÇ genome ¹× protein ¹ßÇö°úÀÇ Â÷À̸¦ ±Ô¸íÇÑ´Ù.
¨è H. pylori¿¡ ÀÇÇØ À¯µµµÇ´Â À§»óÇǼ¼Æ÷ °í»ç±âÀü (apoptosis)¿¡ ´ëÇÑ ÇÙÀü»çÀÎÀÚÀÇ ¿ªÇÒÀ» ±Ô¸íÇÑ´Ù.
H. pylori¿¡ ÀÇÇØ À¯µµµÇ´Â ¼¼Æ÷°í»ç¿¡¼ ¼¼Æ÷°í»ç Á¶Àý°ü·Ã ´Ü¹é ¹× NF-¥êB¿ÍÀÇ °ü·Ã¼º ±Ô¸í ¹× À§»óÇǼ¼Æ÷¿¡¼
H. pylori¿¡ ÀÇÇÑ ÇÙÀü»çÁ¶ÀýÀÎÀÚ¿¡ ´ëÇÑ º¯µ¿À» ¹àÈù´Ù.
¨é ÃéÀå¿°ÀÇ º´Àבּ¸·Î¼ ÃéÀå ¼±¼¼Æ÷ÀÇ ¿°Áõ¸Å°³ cytokine¹ßÇö ¹× Àü»çÁ¶Àý ±âÀüÀ» ±Ô¸íÇÑ´Ù.
A. ÃéÀå¿° À¯µµ½Ã ÃéÀå ¼±¼¼Æ÷¿¡¼ÀÇ È°¼º»ê¼Ò ¼Õ»óÁöÇ¥, NF-¥êB Ȱ¼º ¹× cytokine (IL-1¥â, IL-6)
¹ßÇöÂ÷À̸¦ ±Ô¸íÇÑ´Ù.
B. ÃéÀå¼±¼¼Æ÷ÀÇ Ä£¿°Áõ¼º cytokine¹ßÇö ¹× Àü»çÁ¶Àý ±âÀüÀ» ±Ô¸íÇÑ´Ù.
C. ÃéÀå¿° À¯µµ½Ã ÃéÀå ¼±¼¼Æ÷¿¡¼ÀÇ protein ¹ßÇöÀÇ Â÷À̸¦ ±Ô¸íÇÑ´Ù. |
|
|
|
|
´ëºÐ¾ß:
ÁßÃß½Å°æ ¾à¸®ÇÐ, ºÐÀÚ ¾à¸®ÇÐ |
|
ÁøÇ࿬±¸:
Àü»çÁ¶Àý´Ü¹éÀÎ nuclear factor kappa B °¡ ¼¼Æ÷±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú ±× ÀÀ¿ë
|
|
¿¬±¸
³»¿ë:
bovine cerebral endothelial
cell¿¡¼ ¾Æ·¡ÀÇ ±âÀüÀ» ¿¬±¸Çϰí, À̸¦ ¹ÙÅÁÀ¸·Î
ÇÏ¿© neuron &glial cell system¿¡¼
nuclear factor kappa B°¡ ¼¼Æ÷±â´É¿¡
¹ÌÄ¡´Â ¿µÇâÀ» ±Ô¸íÇÑ´Ù.
Nuclear factor kappa BÀÇ Á¶Àý±âÀü¿¡ ´ëÇÏ¿© ¿¬±¸ÇÑ´Ù.
Nuclear factor kappa B°¡ ¼¼Æ÷±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÏ¿© ¿¬±¸ÇÑ´Ù.
Nuclear factor kappa B°¡ ¼¼Æ÷Ȱ¼º¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ±Ô¸íÇÑ´Ù.
|
|
|
|
|
´ëºÐ¾ß:
½Å°æ Çൿ ¾à¸®ÇÐ |
|
ÁøÇ࿬±¸:
³ú±â´É Àå¾Ö¸¦ ³ú ¹ß´Þ°ú ¿¬°üÁö¾î ¸¶À½-¸ö °ü°è¸¦ (mind-body relationship) °³Ã¼ÀÇ ÀÏ¹Ý ¹×
ÇнÀ Çൿ °Ë»ö°ú ³ú ½Å°æ Àü´Þ ¹°Áú º¯µ¿¿¡ ´ëÇÑ ¾à¸®ÇÐÀû °Ë»ö ¹× Á¶Á÷ ÈÇÐÀû ¹æ¹ýÀ» º´ÇàÇÏ¿© ¿¬±¸ÇÑ´Ù.
³ú ±â´É Àå¾ÖÀÇ ´ë»óÀº ³ú ¹ß´Þ Àå¾Ö, ¾à¹° ³²¿ë, Á¤½ÅÀû ½ºÆ®·¹½º ³ëÃâÀÌ´Ù. Çൿ °Ë»öÀº °¢Á¾ °Ë»ö±â±¸¸¦
ÀÌ¿ëÇÏ¿© Ÿ°í³ Çൿ ¹× ÇнÀÇൿÀ» ´Ù¾çÇÏ°Ô °Ë»öÇϰí, ½Å°æÈÇÐÀû °Ë»öÀº 5-hydroxytryptamine(5-HT)¿¡
ÁßÁ¡À» µÎ¾î ¿¬±¸Çϰí ÀÖÀ¸¸ç 5-HT ¹× °ü·Ã ½Å°æÀü´Þ¹°ÁúÀÇ ÇÔ·®, ¼ö¿ëü º¯µ¿ ¹× »ýÇÕ¼º È¿¼ÒÀÇ À¯ÀüÀÚ
Ç¥Çö Á¤µµ µî ½Å°æÀü´Þ¹°ÁúÀÇ È°¼º º¯µ¿À» Á¾ÇÕÀûÀ¸·Î °Ë»öÇϰí ÀÖ´Ù. ÀÌ·¯ÇÑ ¿¬±¸·Î ³ú±â´ÉÀÌ Ç¥ÃâµÇ´Â ±âÀüÀ»
Ãß±¸ÇÏ¿© ³ú±â´É Àå¾Ö Ä¡·á¿¡ ±â¿©ÇÔÀ» ¸ñÇ¥·Î Çϰí ÀÖ´Ù.
|
|
|
|
|
´ëºÐ¾ß:
¼Òȱ⠾ฮÇÐ, »óÇǼ¼Æ÷ÇÐ |
|
ÁøÇ࿬±¸:
¨ç ¼ÒÈ°è ¼¼Æ÷¸·¿¡ Á¸ÀçÇÏ´Â ¼ö¼Û´Ü¹éÀÇ ¿ªÇÒ°ú ÀÛ¿ë±âÀü ±Ô¸í
¨è ¼ö¼Û´Ü¹é À¯ÀüÀÚ º¯ÀÌ¿Í °ü·ÃµÈ ¾à¹°À¯Àüü ¿¬±¸
|
|
¿¬±¸
³»¿ë:
- ¼¼Æ÷¸·¿¡ Á¸ÀçÇÏ´Â ¼ö¼Û´Ü¹éÀÇ ¿ªÇÒ°ú ÀÛ¿ë±âÀü ±Ô¸í
...A.
¿ÜºÐºñ¼±°ú Àå°ü¼¼Æ÷ÀÇ ³»°¸·¿¡ Á¸ÀçÇÏ´Â ÀÌ¿ÂÅë·Î ¹× ¼ö¼Û´Ü¹éÀÇ
ÀÛ¿ë±âÀü
...B.
»óÇǼ¼Æ÷¸·¿¡ Á¸ÀçÇÏ´Â H+, HCO3--transporterÀÇ
¿ªÇÒ
...C.¼ö¼Û´Ü¹é
±â´É ÀÌ»ó¿¡ ÀÇÇÑ ÀÎü Áúº´±â
- ¾à¹°¼ö¼Û À¯Àüü ¿¬±¸
...A.
Çѱ¹ÀÎ ABC ¼ö¼Û´í¹é À¯ÀüÀÚ º¯ÀÌ ¹ß±¼
...B.
ÀÎü ¾à¹° ¿ªµ¿ ¹× ¾à¹°¹ÝÀÀ°ú °ü·ÃµÈ À¯ÀüÀÚ º¯ÀÌ ±Ô¸í
...C.
¾à¹°¼ö¼Û ´Ü¹é ±â´É¼º º¯ÀÌÀÇ ºÐÀÚ»ý¹°ÇÐÀû ±Ô¸í
|
|
|
|
|
´ëºÐ¾ß:
ÀÓ»ó ¾à¸®ÇÐ |
|
ÁøÇ࿬±¸:
ÀÓ»ó ¾àµ¿ÇÐ, ¾à·ÂÇÐ, ¾à¹°À¯ÀüüÇÐÀû ¿¬±¸¿Í ÀÓ»ó½ÃÇèÀÇ ¼³°è, ÁøÇà ¹× ±â¼ú °³¹ß
|
|
¿¬±¸
³»¿ë:
1. ¾àµ¿·ÂÇÐ ¸ðµ¨¸µ
..* ¾àµ¿ÇÐ ¸ðµ¨¸µ: ¾à¹°ÀÇ Ã¼³»µ¿Å (Èí¼ö, ºÐÆ÷, ´ë»ç,
¹è¼³)¿¡ °üÇÑ ¿¬±¸
..* ¾à·ÂÇÐ ¸ðµ¨¸µ: ¾à¹°ÀÇ ¼ö¿ëü ³óµµ¿Í ÀÓ»óÈ¿°ú¿¡ °üÇÑ
¿¬±¸
..* Áý´Ü¾àµ¿ÇÐ ¸ðµ¨¸µ: È¥ÇÕÈ¿°ú (mixed effect)
¸ðµ¨À» ¾àµ¿·ÂÇÐ ¸ðµ¨¸µ
2. ÀûÁ¤ ¿ë·® ¼³°è
..* Stochastic control, Optimal design
principle µîÀÇ ±â¹ý °³¹ß
..* Therapeutic Drug Monitoring,
½Å¾à°³¹ß µî¿¡ ÀÀ¿ë
3. ¾à¹°À¯ÀüüÇÐ ±â¼ú °³¹ß
..* ¾àµ¿·ÂÇÐ ¹ÝÀÀÀÇ °³ÀÎÂ÷ÀÇ À¯ÀüÀû ¿øÀο¡ °üÇÑ ¿¬±¸
..* ÅëÇÕµÈ ¾àµ¿/¾à·Â/¾à¹°À¯ÀüüÇÐ ¸ðµ¨À» °³¹ßÇÏ¿© ¸ÂÃã¾à¹°¿ä¹ý¿¡
ÀÀ¿ë
4. »ýÅë°è ºÐ¼®
..* Smoothing technique, Convolution/deconvolution,
Time series analysis µîÀÇ
... ±â¹ý °³¹ß* »ýü¹ÝÀÀº¯¼öÀÇ Á¤·®Àû ÇØ¼®¿¡ ÀÀ¿ë (¿¹:
EEG, heart rate)
5. Model-based drug development
..* Bioinformatics ¿Í Simulation À»
ÀÌ¿ëÇÑ ÀûÁ¤ ÀÓ»ó½ÃÇè¼³°è
..* È¿À²Àû ½Å¾à°³¹ß¿¡ ÀÀ¿ë.
|
|
|
|
|
´ëºÐ¾ß:
ÁßÃß½Å°æ ¾à¸®ÇÐ, ºÐÀÚ ¾à¸®ÇÐ |
|
ÁøÇ࿬±¸:
½Å°æ¼¼Æ÷¿¡¼ metabotropic glutamate receptor ÀÇ ¿ªÇÒ°ú Á¶Àý ±âÀü¿¡ °üÇÑ ¿¬±¸
|
|
|
| |
 |
|
Çлý
»ó´ã±³¼ö: À̹α¸ (Àǰú´ëÇÐ ½Å°ü302È£, ¿¬¶ôó: 2228-1737,1730) |
|
Çлý ¸é´ã½Ã°£:
¿ÀÀü 8:30 - 9:30, ¿ÀÈÄ 4:30 - 5:30 |
|
|
| |
 |
|
¾à¸®ÇкоßÀÇ
½ÇÇè¿¡ »ç¿ëµÇ´Â ±âº» ¼ö±âµéÀ» Âü°üÇÑ´Ù. |
|
ÁÖ¾îÁø
°¡¼³À» Áõ¸íÇÒ ¼ö ÀÖ´Â ±âº»ÀûÀÎ ½ÇÇè °èȹÀ» ±¸»óÇÒ ¼ö ÀÖ¾î¾ß ÇÑ´Ù. |
|
ÁÖ¾îÁø
½ÇÇè °á°ú¸¦ ºÐ¼®Çϰí, ³í¸®ÀûÀ¸·Î ¼³¸íÇÒ ¼ö ÀÖ¾î¾ß ÇÑ´Ù. |
|
³í¹®
ÀÛ¼º¹ý¿¡ µû¶ó °¡¼³ Á¦½Ã, ½ÇÇè °èȹ ±¸»óÀ» ±â¼úÇÒ ¼ö ÀÖ¾î¾ß ÇÑ´Ù. |
|
|
| |
 |
|
½ÇÇè
°üÂû ¹× Âü¿© : 2ÀÎ À̳»·Î Á¶¸¦ Â¥¼ 2ÁÖ µ¿¾È ÇÑ ¿¬±¸½ÇÀÇ
¿¬±¸¿¡ Âü¿©ÇÏ¿©?½ÇÇèÀ» ÀÌÇØÇϰí
..Á¶±³¿Í Åä·ÐÇÑ´Ù. |
|
Progress
report : ¾à¸®Çб³½Ç °¢ ½ÇÇè½ÇÀÇ ´ëÇпø»ý ¹× ¿¬±¸¿øÀÌ
¹ßÇ¥ÇÏ´Â °ÍÀ» µè´Â´Ù. |
|
Gastrointestinal
Lab Meeting : ¼Òȱ⠾ฮÇÐ °èÅëÀÇ ½ÇÇè½Ç ´ëÇпø»ý
¹× ¿¬±¸¿øÀÇ ¹ßÇ¥¸¦ µè°í
..Åä·ÐÇÑ´Ù |
|
Neuroscience
Lab Meeting : ½Å°æ ¾à¸®ÇÐ °èÅëÀÇ ½ÇÇè½Ç ´ëÇпø»ý
¹× ¿¬±¸¿øÀÇ ¹ßÇ¥¸¦ µè°í Åä·Ð
..ÇÑ´Ù. |
|
Clinical
Pharmacology Lab Meeting : ÀÓ»ó ¾à¸®ÇÐ
°èÅëÀÇ ½ÇÇè½Ç ´ëÇпø»ý ¹× ¿¬±¸¿øÀÇ ¹ßÇ¥¸¦
..µè°í Åä·Ð
ÇÑ´Ù. |
|
¾à¸®ÇÐ
¼¼¹Ì³ª : ±³½Ç ³»¿ÜÀÇ ´Ù¾çÇÑ ¿¬±¸ÀÚµéÀ» ÃÊûÇÏ¿© ¼¼¹Ì³ª¸¦ µè°í
Åä·ÐÇÑ´Ù. |
|
Review
paper ¹ßÇ¥ : ¹èÁ¤ ¹ÞÀº ¿¬±¸½Ç¿¡¼ ¿¬±¸Çϰí ÀÖ´Â ³»¿ë°ú
°ü·ÃµÈ ÃֽŠreview paper¸¦ Àаí
..³»¿ëÀ» ¹ßÇ¥
¹× Åä·Ð ÇÑ´Ù. |
|
Textbook
review : ¸Å³â ÇѱÇÀÇ ¾à¸®ÇÐ ±³À縦 ¼±Á¤ÇÏ¿© ÇÑ ´Ü¿ø¾¿ÀÇ
³»¿ëÀ» Àаí ÀÓ»óÀû Áö½Ä°ú ¾à¸®
..ÇÐÀû Áö½ÄÀ» ¿¬°èÇÏ¿© ÀÌÇØÇÑ ÈÄ ¹ßÇ¥ ¹× Åä·ÐÇÑ´Ù. |
|
Original
paper ¹ßÇ¥ : ¹èÁ¤ ¹ÞÀº ¿¬±¸½Ç¿¡¼
½ÇÇè¿¡ Âü¿©Çϸç Á¶±³¿Í Åä·ÐÇß´ø Áö½ÄÀ» ¹ÙÅÁÀ¸·Î ÇÏ¿©
..°¡±ÞÀû ÇØ´ç
¿¬±¸½Ç¿¡¼ ÃÖ±Ù ¹ßÇ¥ÇÑ ³í¹®À» ÀÐ°í ¹ßÇ¥ ¹× Åä·ÐÇÑ´Ù. |
|
Research
review : 2ÁÖ µ¿¾È ¹ßÇ¥ÇÑ ³»¿ë°ú ½ÇÇè¿¡ Âü¿©ÇÑ °æÇèÀ»
¹ÙÅÁÀ¸·Î ÇØ´ç ½ÇÇè½ÇÀÇ ¿¬±¸ ³»¿ë
..À» ¹ßÇ¥ÇÑ´Ù. |
|
|
| |
 |
|
| Ç× ¸ñ |
ºñ Áß |
Ãâ¼® ¹× ½Ç½À Âü°¡
ŵµ
|
20% |
| Review paper
¹ßÇ¥ |
10% |
| Original paper
¹ßÇ¥ |
10% |
| Textbook review |
20% |
| Research review |
20% |
| ½ÃÇè (ÀÚÀ²½Å°æ°è) |
20% |
|
|
|
| |
 |
|
1.
Sambrook J, Russell DW, Sambrook J: Molecular
Cloning - A Laboratory Manual, 3rd ed.
... Cold
Spring Harbor Laboratory Press, Cold
Spring Harbor, USA, 2000 |
|
2.
Old RW and Primrose SB: Principles of Gene
Manipulation. 5th ed.
... Blackwell
Scientific Publications, London,
UK, 1994. |
|
|
| |
 |
|
| ¾Æ·¡ÀÇ ¼ö±â Áß
±³À° ´ç½Ã ÁøÇàµÇ°í ÀÖ´Â ½ÇÇè ¼ö±â¸¦ Áß½ÉÀ¸·Î ½Ç½ÀÇÑ´Ù. |
|
Cell
culture
Immunoprecipiation
Fluorescence microscopic assay
in situ immunohistochemical assay
Northern blot
Southern blot
Western blot
Plasmid manipulation
Electric Mobility Shift Assay
Polymerase Chain Reaction
Enzyme Linked Immunosorbent Assay
FACS
RNase Protection Assay
Transfection
Protein Kinase Assay
pH and Calcium Measurement by Spectrofluorometer
Receptor Binding Assay
Animal manipulation
Behavioral Analysis |
|
|
| |
 |
|
| ½Ã°£ |
±¸ºÐ |
¿ù |
È |
¼ö |
¸ñ |
±Ý |
Åä |
| 08:00-09:00 |
½Ç½À³»¿ë |
Progress
Report (8:30-) |
½ÇÇè
°üÂû
¹× Âü¿©
|
¾à¹°
ÀÛ¿ë±âÀü
¼ö¾÷ |
Gastroin
- testinal Laboratory Meeting
(8:30-) |
½ÇÇè
°üÂû
¹× Âü¿© |
Neroscience
Lab
Meeting
(8:00-) |
| ´ã´ç±³¼ö |
¾È¿µ¼ö |
| 09:00-10:00 |
½Ç½À³»¿ë |
½ÇÇè
°üÂû
¹× Âü¿© |
| ´ã´ç±³¼ö |
¾È¿µ¼ö |
¾È¿µ¼ö |
±è°æÈ¯ |
| 10:00-11:00 |
½Ç½À³»¿ë |
½ÇÇè
°üÂû
¹× Âü¿© |
½ÇÇè
°üÂû
¹× Âü¿© |
½ÇÇè
°üÂû
¹× Âü¿© |
| ´ã´ç±³¼ö |
| 11:00-12:00 |
½Ç½À³»¿ë |
| ´ã´ç±³¼ö |
| 12:00-13:00 |
½Ç½À³»¿ë |
| ´ã´ç±³¼ö |
ÇØ´ç ±³¼ö |
| 13:00-14:00 |
½Ç½À³»¿ë |
|
| ´ã´ç±³¼ö |
| 14:00-15:00 |
½Ç½À³»¿ë |
| ´ã´ç±³¼ö |
| 15:00-16:00 |
½Ç½À³»¿ë |
| ´ã´ç±³¼ö |
| 16:00-17:00 |
½Ç½À³»¿ë |
| ´ã´ç±³¼ö |
ÇØ´ç ±³¼ö |
ÇØ´ç ±³¼ö |
ÇØ´ç ±³¼ö |
| 17:00-18:00 |
½Ç½À³»¿ë |
Review
Paper (1ÁÖ)
Original Paper (2ÁÖ)
¹ßÇ¥ |
¾à¸®ÇÐ
¼¼¹Ì³ª |
Textbook
Review
(1ÁÖ)
/
Research Review¿Í
½ÃÇè (2ÁÖ) |
| ´ã´ç±³¼ö |
ÇØ´ç
±³¼ö |
À̹α¸ |
ÇØ´ç
±³¼ö |
±èµ¿±¸ |
À̹α¸ |
|
|
|
|
|
| |
|
|
|